Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yesim Ozguler

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
Arthritis Care & Research|February 12, 2016
Recommendations in the American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis Related to the Use of Biologic Agents in Patients With a History of Cancer Need Reconsideration: Comment on the Article by Singh et alHasan Yazici, Yesim Ozguler, Gulen Hatemi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 12, 2016
Recommendations in the American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis Related to the Use of Biologic Agents in Patients With a History of Cancer Need Reconsideration: Comment on the Article by Singh et alHasan Yazici, Yesim Ozguler, Gulen Hatemi, et al.
Pharmacoepidemiology and Drug Safety|June 20, 2018
Assessing the possible association of anti-TNF use with new malignancies: A neglected methodological considerationYesim Ozguler, Yusuf Yazici, Gulen Hatemi, et al.
Current Opinion in Immunology|March 17, 2026
A critical look at the evolution of randomized controlled trials: new and old ethical issuesHasan Yazici, Yesim Ozguler, Sinem N Esatoglu, et al.
Trials|January 25, 2025
Safety outcome trials in four mainline medical journals 30 years apart: a narrative review and the need for the transparency of informed consentsSinem Nihal Esatoglu, Ayse Ozdede, Yesim Ozguler, et al.
European Journal of Internal Medicine|October 11, 2016
Inadequate reporting of enrolled patient and study site characteristics, and inter-study site differences in randomized controlled trials: A systematic review in six leading medicine journalsSebahattin Yurdakul, Gizem Ayan, Yesim Ozguler, et al.
Annals of the Rheumatic Diseases|November 27, 2021
Challenges in optimising patient participation in research: do patients participating in meetings represent the actual patient population with Behçet's syndrome?Sıtkı Safa Taflan, Sinem Nihal Esatoglu, Yesim Ozguler, et al.
Indian Journal of Ophthalmology|August 23, 2020
Investigation of clinical profile of Behçet's syndrome-related versus idiopathic branch retinal vein occlusionDidar Ucar, Burak Mergen, Busenur Gonen, et al.
Clinical and Experimental Rheumatology|December 25, 2018
Faecal but not serum calprotectin levels look promising in predicting active disease in Behçet's syndrome patients with gastrointestinal involvementSinem Nihal Esatoglu, Ibrahim Hatemi, Yesim Ozguler, et al.
Clinical and Experimental Rheumatology|January 10, 2024
Pulmonary artery involvement due to Behçet's syndrome and Hughes Stovin syndrome: a comparative studyBaver Ordu, Muhammed Şamil Aslan, Yesim Ozguler, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Arthritis Care & Research|February 12, 2016
Recommendations in the American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis Related to the Use of Biologic Agents in Patients With a History of Cancer Need Reconsideration: Comment on the Article by Singh et alHasan Yazici, Yesim Ozguler, Gulen Hatemi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 12, 2016
Recommendations in the American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis Related to the Use of Biologic Agents in Patients With a History of Cancer Need Reconsideration: Comment on the Article by Singh et alHasan Yazici, Yesim Ozguler, Gulen Hatemi, et al.
Pharmacoepidemiology and Drug Safety|June 20, 2018
Assessing the possible association of anti-TNF use with new malignancies: A neglected methodological considerationYesim Ozguler, Yusuf Yazici, Gulen Hatemi, et al.
Current Opinion in Immunology|March 17, 2026
A critical look at the evolution of randomized controlled trials: new and old ethical issuesHasan Yazici, Yesim Ozguler, Sinem N Esatoglu, et al.
Trials|January 25, 2025
Safety outcome trials in four mainline medical journals 30 years apart: a narrative review and the need for the transparency of informed consentsSinem Nihal Esatoglu, Ayse Ozdede, Yesim Ozguler, et al.
European Journal of Internal Medicine|October 11, 2016
Inadequate reporting of enrolled patient and study site characteristics, and inter-study site differences in randomized controlled trials: A systematic review in six leading medicine journalsSebahattin Yurdakul, Gizem Ayan, Yesim Ozguler, et al.
Annals of the Rheumatic Diseases|November 27, 2021
Challenges in optimising patient participation in research: do patients participating in meetings represent the actual patient population with Behçet's syndrome?Sıtkı Safa Taflan, Sinem Nihal Esatoglu, Yesim Ozguler, et al.
Indian Journal of Ophthalmology|August 23, 2020
Investigation of clinical profile of Behçet's syndrome-related versus idiopathic branch retinal vein occlusionDidar Ucar, Burak Mergen, Busenur Gonen, et al.
Clinical and Experimental Rheumatology|December 25, 2018
Faecal but not serum calprotectin levels look promising in predicting active disease in Behçet's syndrome patients with gastrointestinal involvementSinem Nihal Esatoglu, Ibrahim Hatemi, Yesim Ozguler, et al.
Clinical and Experimental Rheumatology|January 10, 2024
Pulmonary artery involvement due to Behçet's syndrome and Hughes Stovin syndrome: a comparative studyBaver Ordu, Muhammed Şamil Aslan, Yesim Ozguler, et al.
Pageof 6